Dr. Ania Jastreboff, an expert in obesity treatments from Yale, and Dr. Rachel Goldman, a clinical psychologist from NYU, discuss the transformative effects of GLP-1 medications on both physical health and mental well-being. They dive into personal stories of individuals who experienced significant weight loss and the stark shift in how they're treated socially. The conversation sheds light on the emotional complexities tied to body image and identity, as well as the need for greater understanding of obesity as a disease impacting both healthcare and societal perceptions.

Dr. Ania Jastreboff, an endocrinologist and GLP-1 medication expert from Yale, dives into the complex biology of obesity and the revolutionary role of medications like Ozempic and Wegovy. She explains why some struggle to lose weight and why obesity is a disease requiring more than willpower. Personal stories highlight transformative journeys with these medications, addressing misconceptions and stigma surrounding weight loss treatments. The conversation advocates for a compassionate approach to obesity management and emphasizes the importance of continuous support and understanding.